Clinical Trials
7 trialsNCT01272817 2022-11-23
Mini-allo
Scripps Health
Phase NA Completed
NCT01364363 2022-11-23
Unrelated Donor Stem Cell Transplantation
Scripps Health
Phase NA Completed
NCT00856388 2019-11-13
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders
Roswell Park Cancer Institute
Phase NA Completed
NCT01529827 2019-09-24
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Roswell Park Cancer Institute
Phase 2 Completed
NCT00997386 2019-09-09
ALBUM
University of Arizona
Phase 2 Completed
NCT00618969 2016-03-03
Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors
University of Arizona
Phase 2 Completed
NCT00975975 2016-02-26
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer
Indiana University
Phase 2 Completed